Japan's Terumo Sues Olympus Over Share Losses Related To Scandal
This article was originally published in PharmAsia News
Japan medical device maker Terumo has sued Olympus, also a maker of medical equipment, over losses Terumo experienced with its 2.1% equity stake in the troubled firm.
You may also be interested in...
The company has come a long way since gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.